Solesence, Inc SLSN 深 沪
已收盘 02-06 16:00:00 美东时间
1.37
+0.040
+3.01%
华盛通- 最 高1.43
- 今 开1.38
- 成交量 3.21万股
- 最 低 1.338
- 昨 收 1.33
- 总市值 9663.55万
- 52周最高 16.56
- 市盈率 静 21.04
- 换手率 0.05%
- 52周最低 1.255
- 委 比 0.00%
- 总股本 7053.68万
- 历史最高 16.56
- 量 比 0.66
- 振 幅 6.92%
- 历史最低 1.255
- 每 手 1
- 风险率 0.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多电话会总结 ｜ Solesence(SLSN)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Solesence业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **第三季度核心财务数据：** - 营收：1,450万美元，同比下降14% - 毛利润：340万美元，毛利率23%（去年同期为610万美元，毛利率36%） - 净亏损：110万美元（去年同期净利润300万美元） - 调整后EBITDA：亏损43.5万美元（去年同期盈利360万美元） - 运营费用：420万美元，较去年同期290万美元大幅增长 **全年业绩表现：** - 前三季度累计营收同比增长1,000万美元 - 在建订单达6,400万美元，较去年同期3,400万美元大
2025-11-12 12:26
Solesence Q3 EPS $(0.02) Down From $0.04 YoY, Sales $14.597M Down From $16.866M YoY
Solesence (NASDAQ:SLSN) reported quarterly losses of $(0.02) per share. This is a 150 percent decrease over earnings of $0.04 per share from the same period last year. The company reported $14.597 million in sales this
2025-11-11 20:01
Earnings Scheduled For November 11, 2025
Companies Reporting Before The Bell • Gogoro (NASDAQ:GGR) is estimated to repor...
2025-11-11 19:11
Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call
Solésence, Inc. announces it will report third quarter 2025 results on November 11, 2025, before market open, and host a conference call and webcast at 7:30 a.m. CDT (8:30 a.m. EDT). The call will feature Kevin Cureton, President & CEO, Laura Riffner, CFO, and Jess Jankowski, Board Advisor. Registration is required for dial-in access, and a webcast link is available on the investor relations website. For more details, visit [https://ir.solesence....
2025-10-30 12:00
Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth
Solésence, Inc. appoints Kevin Cureton as President and CEO, Laura Riffner as CFO, and Jess Jankowski as Board Advisor in its ongoing strategic transformation. These changes follow the company's rebranding and Nasdaq listing, focusing on innovation and growth in skin health solutions.
2025-09-03 12:00
Solesence shares are trading lower following the release of its Q2 financial results.
Solesence shares are trading lower following the release of its Q2 financial re...
2025-08-01 21:12
Solesence Q2 EPS $0.04, Sales $20.26M
Solesence (NASDAQ:SLSN) reported quarterly earnings of $0.04 per share. The company reported $20.26 million in sales this quarter.
2025-08-01 04:04
Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call
Solésence Inc. announced it will release its Q2 2025 results after market close on July 31, 2025, and host a conference call/webcast at 4:00 p.m. CDT (5:00 p.m. EDT) featuring President & CEO Jess Jankowski and COO Kevin Cureton.
2025-07-24 12:00
Solésence To Join Russell 3000 And Russell 2000 Indexes, Effective June 30, 2025
Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it will be added as a member of the broad-market Russell 3000®
2025-06-24 20:14
Solésence to Join Russell 3000® and Russell 2000® Indexes
Illinois-based Solésence, Inc. (Nasdaq: SLSN) has been added to Russell's broad-market Russell 3000® and small-cap Russell 2000® Indexes, effective June 30, 2025, as part of the 2025 Russell indexes reconstitution. This inclusion, following its recent Nasdaq listing, enhances its visibility to institutional investors and supports its growth in developing innovative skin health solutions. Russell indexes, managed by FTSE Russell, benchmark around ...
2025-06-24 12:00
